On April 26, 2022 Targovax ASA reported that members of its executive management team are invited for oral presentations and a panel discussion at the 5th Neoantigen Summit Europe in Amsterdam 27-28 April (Press release, Targovax, APR 26, 2022, View Source [SID1234612948]).

Schedule your 30 min Free 1stOncology Demo!
Discover why more than 1,500 members use 1stOncology™ to excel in:

Early/Late Stage Pipeline Development - Target Scouting - Clinical Biomarkers - Indication Selection & Expansion - BD&L Contacts - Conference Reports - Combinatorial Drug Settings - Companion Diagnostics - Drug Repositioning - First-in-class Analysis - Competitive Analysis - Deals & Licensing

                  Schedule Your 30 min Free Demo!

Presentation: Uncovering the Benefits of Personalized Vaccines in a Clinical Setting
Presenter: Dr. Erik Digman Wiklund (CEO)
Date: 27 April 2022
Time: 10:00 CET

Presentation: Clinical Combination Strategies with Oncolytic Vaccines in Solid Tumors
Presenter: Dr. Victor Levitsky (CSO)
Date: 28 April 2022
Time: 15:30 CET

Panel Discussion: Evaluating Combination Therapies to Maximize Anti-Tumour Immune Activity
Participants from Targovax: Erik Digman Wiklund (CEO), Victor Levitsky (CSO)
Date: 28 April 2022
Time: 16:00 CET